Search
for
Sort by
Research 871–900 of 1000+
- Safety of testosterone treatment in postmenopausal women
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Clinical and biological impact of the exposome on the skin
- Diagnosis of hyperandrogenism: Biochemical criteria
- BENIGN PREMATURE ADRENARCHE: CLINICAL FEATURES AND SERUM STEROID LEVELS
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Testosterone Metabolism in the Skin
- 18β‐Glycyrrhetinic acid: its core biological properties and dermatological applications
- Potential adverse effects of long-term testosterone therapy
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- Insulin Resistance and Skin Diseases
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Short-Chain Fatty Acids from <i>Cutibacterium acnes</i> Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- The SAHA Syndrome
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Dermatology of androgen-related disorders
- Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents
- Hidradenitis suppurativa
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Dienogest
- Prevalence of most common skin diseases in Europe: a population‐based study
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Polycystic ovary syndrome: A review for dermatologists
- Keratin 79 identifies a novel population of migratory epithelial cells that initiates hair canal morphogenesis and regeneration
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Lipid Nanoparticles Based Cosmetics with Potential Application in Alleviating Skin Disorders